Glycine can increase serotonin levels in certain parts of the brain, but the relationship is more complex than a simple boost. In a rat study, oral glycine raised extracellular serotonin in the prefrontal cortex within minutes, while leaving dopamine unchanged. However, glycine also acts on inhibitory receptors in other brain regions where it can actually suppress serotonin release. The net effect depends on the dose, the brain region involved, and which of glycine’s multiple receptor pathways dominates.
How Glycine Raises Serotonin in the Prefrontal Cortex
The most direct evidence comes from a microdialysis study in rats. When glycine was given orally at doses of 1 or 2 grams per kilogram of body weight, serotonin levels in the prefrontal cortex rose significantly within about 10 minutes. Dopamine levels did not change. The researchers noted that this transient serotonin increase might help explain two observations from human studies: improvements in sleep quality among people with insomnia who take glycine, and reduced negative symptoms (like social withdrawal and flat mood) in people with schizophrenia receiving glycine as an add-on treatment.
This serotonin-boosting effect likely works through NMDA receptors, a type of receptor that controls excitatory signaling throughout the brain. NMDA receptors need two things to activate: glutamate and glycine. Glycine binds to a specific site on the receptor, and without it, the receptor stays closed regardless of how much glutamate is present. By filling that glycine site more completely, supplemental glycine can enhance NMDA receptor activity, which in turn stimulates serotonin release in regions like the prefrontal cortex.
Where Glycine Suppresses Serotonin Instead
Glycine doesn’t only work through NMDA receptors. It also activates its own dedicated inhibitory receptors, particularly in the brainstem’s raphe nuclei, which are the brain’s primary serotonin-producing cells. In cell culture experiments using raphe neurons, glycine at moderate concentrations decreased both serotonin release and serotonin synthesis. This inhibitory effect was completely blocked by strychnine, a compound that specifically blocks glycine’s inhibitory receptors, confirming that this suppression happens through a separate pathway from the NMDA mechanism.
The distinction matters. In the prefrontal cortex, where NMDA receptors are abundant, glycine tends to increase serotonin. In the raphe nuclei, where inhibitory glycine receptors are densely expressed, it tends to decrease serotonin output. Both effects are real, and both happen in the same brain at the same time. The overall impact on your mood or sleep likely reflects the balance between these competing actions.
What This Means at Supplement Doses
Human studies exploring glycine’s brain effects have used a wide range of doses. For neurological and psychiatric applications, clinical trials have typically used 0.8 grams per kilogram of body weight per day, which works out to roughly 56 grams daily for a 70-kilogram (154-pound) person. Some trials have gone as high as 60 grams per day, often split into multiple doses. For sleep quality specifically, the commonly studied dose is much lower, around 3 grams taken before bed.
These are very different dosing ranges, and the serotonin effects at a 3-gram bedtime dose are unlikely to match those seen in animal studies using gram-per-kilogram amounts. The rat study that demonstrated increased prefrontal serotonin used oral doses equivalent to human clinical trial ranges (scaled for body weight), suggesting that meaningful serotonin changes require substantial intake. At the lower supplement doses many people take, glycine’s sleep benefits may rely more on its body-cooling effects and its inhibitory signaling in the brainstem than on serotonin elevation.
Interactions With Other Serotonin Pathways
One consideration for anyone taking serotonin-active medications: glycine’s relationship with drugs like SSRIs is not straightforward. In animal research examining forced swim tests (a common model for antidepressant effects), compounds that activate the glycine site on NMDA receptors sometimes interfered with the antidepressant-like effects of SSRIs. In one experiment, d-serine, which acts on the same NMDA receptor site as glycine, abolished the antidepressant effect of fluoxetine when the two were given together.
This doesn’t necessarily mean glycine supplements cancel out antidepressants in humans. The interactions observed were complex and dose-dependent, and animal models of depression have well-known limitations. But it does suggest that glycine’s effects on the serotonin system are not simply additive with existing serotonergic drugs.
Glycine and Tryptophan: A Potential Tradeoff
There’s one more layer to consider. Your brain makes serotonin from tryptophan, an amino acid that must cross the blood-brain barrier to reach serotonin-producing neurons. Tryptophan shares its transport system with several other amino acids, and when competing amino acids are present in high concentrations in the blood, less tryptophan gets through. While glycine itself uses a different primary transporter, large doses of amino acids can shift the overall balance of amino acid competition in plasma, potentially affecting how much tryptophan reaches the brain. This is a theoretical concern rather than a demonstrated problem with glycine specifically, but it’s worth noting for anyone taking very high doses.
The bottom line: glycine does increase serotonin in specific brain regions through its role as an NMDA receptor co-activator, while simultaneously suppressing serotonin in others through its inhibitory receptors. Whether the net result is a meaningful serotonin boost for you depends heavily on the dose and what else is happening in your neurochemistry.